Lung Injury: Clinical Trials

92 trials for Lung Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

42 completed, 20 unknown, 10 terminated, 9 recruiting. 92 Phase 1, 39 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 192Completed 42, Unknown 20, Terminated 10, Recruiting 9, Withdrawn 9, Active not recruiting 1, Not yet recruiting 1
Phase 239Completed 15, Unknown 10, Terminated 6, Recruiting 5, Withdrawn 2, Not yet recruiting 1

Follow Lung Injury: new trials by email Literature Review of Lung Injury trials Research Report on Lung Injury

Trials (filtered) newest first · largest first

All 92 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of GKL-006RTU in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS)
GKL-006RTU injection, Placebo - ARDS (Acute Respiratory Distress Syndrome)
Phase 1 / Phase 2Not yet recruitingBeijing Gene Key Life Technology Co., Ltd522026-11-102026-09-30
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
High-energy group, Standard-energy group - Extreme Prematurity, Enteral Nutrition
Phase 1 / Phase 2RecruitingUniversity of Alabama at Birmingham1502026-09-212026-09-24
129Xe MRI in Pediatric Population With BPD
MagniXene, hyperpolarized 129Xe MRI - Bronchopulmonary Dysplasia
Phase 1WithdrawnXemed LLC2026-08-012026-02-05
Pharmacokinetics and Placental Transfer of Caffeine
Caffeine citrate - Preterm Labor With Preterm Delivery, Premature Birth
Phase 1RecruitingIndiana University302026-06-012026-06-04
Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
HT31-1, Saline (0.9%, sterile, for infusion) - ARDS (Acute Respiratory Distress Syndrome)
Phase 1RecruitingHTIC, Inc242026-05-282026-09-16
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
montelukast 4 mg granule, Placebo - Bronchopulmonary Dysplasia (BPD), Premature Births
Phase 1 / Phase 2RecruitingDuke University282026-02-232026-07-14
Inhaled Ciclesonide Study in Preterm Infants
Alvesco Inhalant Product - Bronchopulmonary Dysplasia
Phase 1RecruitingVenkatesh Sampath302025-09-162026-09-09
Inhaled Treatment for Bronchopulmonary Dysplasia
GSNO - Bronchopulmonary Dysplasia
Phase 1WithdrawnUniversity Hospitals Cleveland Medical Center2025-08-012025-08-22
Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants
MSC - BPD - Bronchopulmonary Dysplasia
Phase 1 / Phase 2RecruitingThe Children's Hospital of Zhejiang University School of Medicine102024-08-092025-01-23
Different Levels of BiPAP
BiPAP setting - Bronchopulmonary Dysplasia
Phase 1 / Phase 2UnknownKing's College Hospital NHS Trust212024-05-232024-06-11
Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease
Recombinant fragment of human surfactant protein D (rfhSP-D) - Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant
Phase 1CompletedUniversity College, London182024-04-062026-04-07
Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants
Endotracheopulmonary Instillation, Suspension - Bronchopulmonary Dysplasia
Phase 1 / Phase 2RecruitingEXO Biologics S.A.2652023-12-282024-09-19
Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis
single-cell sequencing - Pneumonitis
Phase 1 / Phase 2RecruitingXinqiao Hospital of Chongqing402023-08-012025-07-14
Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
mesenchymal stem cells, saline - Lung Injury
Phase 1 / Phase 2UnknownCell Energy Life Sciences Group Co. LTD802023-05-102024-05-16
The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis
The formulation of Compound Phellinus igniarius decoction - Radiation Pneumonitis
Phase 1CompletedZhejiang Cancer Hospital402023-03-222025-03-11
Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia
Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells - Bronchopulmonary Dysplasia
Phase 1Active not recruitingOttawa Hospital Research Institute92022-10-172025-07-16
Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air
0.070 ppm ozone concentration, Clean air (0.0 ppm ozone) - Lung Injury, Acute, Symptoms and Signs
Phase 1UnknownMartin W. Case602022-10-132023-01-11
Inhaled Tobramycin in BPD
Tobramycin solution for inhalation 78mg dose, Tobramycin solution for inhalation 150mg dose, Tobramycin solution for inhalation 216mg dose - Bronchopulmonary Dysplasia
Phase 1CompletedErik Allen Jensen272022-03-222025-01-31
Anakinra for Preterm Infants Pilot
Anakinra - Prematurity; Extreme, Inflammation
Phase 1 / Phase 2UnknownMonash Medical Centre252022-02-152024-09-19
TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation
Nezulcitinib (TD-0903) Dose A, Nezulcitinib (TD-0903) Dose B - Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)
Phase 1CompletedTheravance Biopharma142021-10-132021-12-10

Showing 20 of 92. Sign in to see all of them.

Narrower conditions

Bronchopulmonary Dysplasia (40)  ·  Acute Lung Injury (34)  ·  Respiratory Distress Syndrome (22)  ·  Premature Birth (15)  ·  COVID-19 (11)  ·  Pneumonia (7)  ·  Lung Diseases (6)  ·  Respiratory Insufficiency (6)  ·  Sepsis (5)  ·  Hypertension, Pulmonary (4)  ·  Coronavirus Infections (3)  ·  Inflammation (3)  ·  Respiration Disorders (3)  ·  Berylliosis (2)

Broader conditions

Respiratory Tract Diseases (91)  ·  Lung Diseases (86)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (40)  ·  Infant, Newborn, Diseases (39)  ·  Ventilator-Induced Lung Injury (39)  ·  Infant, Premature, Diseases (38)  ·  Respiration Disorders (28)  ·  Infections (21)  ·  Pathological Conditions, Signs and Symptoms (17)  ·  Female Urogenital Diseases and Pregnancy Complications (15)  ·  Obstetric Labor Complications (15)  ·  Pregnancy Complications (15)  ·  Respiratory Tract Infections (15)  ·  Urogenital Diseases (15)

Interventions

Sodium Chloride (4)  ·  Ascorbic Acid (2)  ·  Budesonide (2)  ·  GSK1995057 (2)  ·  Saline Solution (2)  ·  montelukast (2)  ·  nezulcitinib (2)  ·  ALT-836 (1)  ·  Azithromycin (1)  ·  Bronchoalveolar Lavage (1)  ·  Cell Count (1)  ·  Clinical Trials, Phase I as Topic (1)  ·  Clinical Trials, Phase II as Topic (1)  ·  Continuous Positive Airway Pressure (1)  ·  Heart Rate (1)

Sponsors

GlaxoSmithKline (4)  ·  Children's Hospital of Chongqing Medical University (3)  ·  Children's Hospital of Philadelphia (3)  ·  Affiliated Hospital to Academy of Military Medical Sciences (2)  ·  Mayo Clinic (2)  ·  NICHD Neonatal Research Network (2)  ·  Theravance Biopharma (2)  ·  University of Alabama at Birmingham (2)  ·  AdventHealth (1)  ·  Airway Therapeutics, Inc. (1)  ·  Altor BioScience (1)  ·  Apellis Pharmaceuticals, Inc. (1)  ·  Beijing Chao Yang Hospital (1)  ·  Beijing Gene Key Life Technology Co., Ltd (1)  ·  Cell Energy Life Sciences Group Co. LTD (1)

Countries

United States (44)  ·  China (16)  ·  United Kingdom (9)  ·  Canada (6)  ·  Spain (4)  ·  Australia (3)  ·  Belgium (2)  ·  Brazil (2)  ·  New Zealand (2)  ·  Taiwan (2)  ·  Ireland (1)  ·  Italy (1)  ·  Poland (1)  ·  Russia (1)  ·  Saudi Arabia (1)

Top investigators

Zhou Fu (3)  ·  Bing Liu, M.D. (2)  ·  Charles R. Bauer, MD (2)  ·  Edward F. Donovan, MD (2)  ·  Alan Davidson, MD (1)  ·  Alexander Binning, MD (1)  ·  Alpha Fowler, MD (1)  ·  Andy Ghio, M.D. (1)  ·  Anna Thomas, MD (1)  ·  Ariel A. Salas, MD, MSPH (1)  ·  Avroy A. Fanaroff, MD (1)  ·  Bai-Horng Su, MD, PhD (1)

Results publications

PMID 24508444, PMID 10379020, PMID 15342835, PMID 15713907, PMID 15774846, PMID 22340260, PMID 22974830, PMID 23364976, PMID 23370599, PMID 24484547, PMID 24503265, PMID 24690891, PMID 24891325, PMID 25529339, PMID 25593740, PMID 26059242, PMID 26178412, PMID 26400297, PMID 26544934, PMID 26547399, PMID 26643677, PMID 28821525, PMID 29021519, PMID 29382797, PMID 30175268, PMID 30992220, PMID 32006953, PMID 34004189, PMID 34473343, PMID 36038890, PMID 36104785, PMID 36389766, PMID 37223507, PMID 37549675, PMID 37640809, PMID 39153779, PMID 39643111, PMID 41018057, PMID 9179535

NIH funding

M01RR008084 (2), U10HD021364 (2), U10HD021397 (2), U10HD027853 (2), U10HD034216 (2), 1UL1RR025780 (1), 2017 (1), 2019 (1), M01RR000070 (1), M01RR000080 (1), M01RR000750 (1), M01RR000997 (1), M01RR006022 (1), M01RR016587 (1), R01HD113201 (1)